# Central Florida Health Care, Inc.

Health Center, FL
Page: https://astrelis.co/providers/health_center/681137  
This twin: https://astrelis.co/providers/health_center/681137.md  
CMS Certification Number (CCN): 681137  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2023)

- **Total patients (UDS) (FY2024):** 79,552. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2022):** -59.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 27. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 18.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2022):** $0.6M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2022):** -46.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Central Florida Health Care, Inc., FL

Match to this profile: matched by name (method: name and state).

- FY ending 2025-01-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-01-GSAFAC-0000377962
- FY ending 2024-01-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-01-GSAFAC-0000051102
- FY ending 2023-01-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-01-GSAFAC-0000001302

| Line | FY ending 2025-01-31 | FY ending 2024-01-31 | FY ending 2023-01-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 44,376,141 [derived, p.6] | 33,548,971 [derived, p.6] | 28,651,803 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 7,708,967 [derived, p.6] | 6,898,063 [derived, p.6] | 6,545,742 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 1,012,198 [derived, p.6] | 1,307,066 [derived, p.6] | 1,110,282 [derived, p.6] |
| other current assets (Statement of financial position) | 1,981,828 [derived, p.6] | 1,529,270 [derived, p.6] | 1,141,903 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 55,079,134 [extracted, p.6] | 43,283,370 [extracted, p.6] | 37,449,730 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 37,349,306 [derived, p.6] | 26,059,029 [derived, p.6] | 23,682,826 [derived, p.6] |
| other long-term assets (Statement of financial position) | 15,540,913 [derived, p.6] | 1,757,142 [derived, p.6] | 1,324,840 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 107,969,353 [extracted, p.6] | 71,099,541 [extracted, p.6] | 62,457,396 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 8,448,956 [derived, p.6] | 6,823,542 [derived, p.6] | 5,608,547 [derived, p.6] |
| deferred revenue (Statement of financial position) | 185,291 [derived, p.6] | 220,558 [derived, p.6] | 136,354 [derived, p.6] |
| current debt and leases (Statement of financial position) | 931,219 [derived, p.6] | 700,563 [derived, p.6] | 1,533,095 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 9,565,466 [extracted, p.6] | 7,744,663 [extracted, p.6] | 7,277,996 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 5,461,093 [derived, p.6] | 1,977,126 [derived, p.6] | 5,611,558 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 18,722,824 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 33,749,383 [extracted, p.6] | 9,721,789 [extracted, p.6] | 12,889,554 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 73,955,518 [derived, p.6] | 61,142,388 [derived, p.6] | 49,340,602 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 264,452 [derived, p.6] | 235,364 [derived, p.6] | 227,240 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 74,219,970 [extracted, p.6] | 61,377,752 [extracted, p.6] | 49,567,842 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 36,053,685 [derived, p.7] | 32,901,322 [derived, p.7] | 29,634,869 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 35,232,886 [derived, p.7] | 28,586,212 [derived, p.7] | 20,439,710 [derived, p.7] |
| federal grants (Statement of activities) | 11,036,761 [derived, p.7] | 10,791,506 [derived, p.7] | 15,285,829 [derived, p.7] |
| other grants and contracts (Statement of activities) | 8,484,239 [derived, p.7] | 5,673,132 [derived, p.7] | 4,920,929 [derived, p.7] |
| contributions (Statement of activities) | 5,616,173 [derived, p.7] | 4,771,401 [derived, p.7] | 3,189,237 [derived, p.7] |
| other revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 96,423,744 [extracted, p.7] | 82,723,573 [extracted, p.7] | 73,470,574 [extracted, p.7] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 84,929,672 [extracted, p.7] | 71,519,137 [extracted, p.7] | 60,105,431 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | 11,494,072 [extracted, p.7] | 11,204,436 [extracted, p.7] | 13,365,143 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 1,348,146 [derived, p.7] | 605,474 [derived, p.7] | 4,137,785 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | 12,842,218 [extracted, p.7] | 11,809,910 [extracted, p.7] | 17,502,928 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 61,377,752 [extracted, p.7] | 49,567,842 [extracted, p.7] | 32,064,914 [extracted, p.7] |
| net assets, end (Statement of activities) | 74,219,970 [extracted, p.7] | 61,377,752 [extracted, p.7] | 49,567,842 [extracted, p.7] |

| Ratio | FY ending 2025-01-31 | FY ending 2024-01-31 | FY ending 2023-01-31 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 5.76x [plausible] | 5.59x [plausible] | 5.15x [plausible] |
| Operating margin | 11.9% [plausible] | 13.5% [plausible] | 18.2% [plausible] |
| Total margin | 13.3% [plausible] | 14.3% [plausible] | 23.8% [plausible] |
| Patient revenue share | 37.4% [plausible] | 39.8% [plausible] | 40.3% [plausible] |
| Grant dependency | 20.2% [plausible] | 19.9% [plausible] | 27.5% [plausible] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 78 days [plausible] | 77 days [plausible] | 81 days [plausible] |
| Debt to net assets | 0.09x [plausible] | 0.04x [plausible] | 0.14x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Central Florida Health Care, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Central Florida Health Care, Inc.", https://astrelis.co/providers/health_center/681137, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.